The need for translational research on drug-drug interactions

S. Hennessy, D. A. Flockhart

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Drug-drug interactions (DDIs) are an important clinical and public health concern. Although DDI screening now occurs during drug development, it is difficult to predict clinical importance based on in vitro experiments. Furthermore, older drugs that were not screened may have interactions that have not yet been identified. In this Commentary, we review the importance of DDIs and argue that a translational research approach is needed to produce clinically actionable information as well as generalizable biological knowledge.

Original languageEnglish
Pages (from-to)771-773
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume91
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Translational Medical Research
Drug Interactions
Pharmaceutical Preparations
Preclinical Drug Evaluations
Public Health

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

The need for translational research on drug-drug interactions. / Hennessy, S.; Flockhart, D. A.

In: Clinical Pharmacology and Therapeutics, Vol. 91, No. 5, 05.2012, p. 771-773.

Research output: Contribution to journalArticle

Hennessy, S. ; Flockhart, D. A. / The need for translational research on drug-drug interactions. In: Clinical Pharmacology and Therapeutics. 2012 ; Vol. 91, No. 5. pp. 771-773.
@article{6b134811f2c8464f9b9d457562ce3cba,
title = "The need for translational research on drug-drug interactions",
abstract = "Drug-drug interactions (DDIs) are an important clinical and public health concern. Although DDI screening now occurs during drug development, it is difficult to predict clinical importance based on in vitro experiments. Furthermore, older drugs that were not screened may have interactions that have not yet been identified. In this Commentary, we review the importance of DDIs and argue that a translational research approach is needed to produce clinically actionable information as well as generalizable biological knowledge.",
author = "S. Hennessy and Flockhart, {D. A.}",
year = "2012",
month = "5",
doi = "10.1038/clpt.2012.39",
language = "English",
volume = "91",
pages = "771--773",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - The need for translational research on drug-drug interactions

AU - Hennessy, S.

AU - Flockhart, D. A.

PY - 2012/5

Y1 - 2012/5

N2 - Drug-drug interactions (DDIs) are an important clinical and public health concern. Although DDI screening now occurs during drug development, it is difficult to predict clinical importance based on in vitro experiments. Furthermore, older drugs that were not screened may have interactions that have not yet been identified. In this Commentary, we review the importance of DDIs and argue that a translational research approach is needed to produce clinically actionable information as well as generalizable biological knowledge.

AB - Drug-drug interactions (DDIs) are an important clinical and public health concern. Although DDI screening now occurs during drug development, it is difficult to predict clinical importance based on in vitro experiments. Furthermore, older drugs that were not screened may have interactions that have not yet been identified. In this Commentary, we review the importance of DDIs and argue that a translational research approach is needed to produce clinically actionable information as well as generalizable biological knowledge.

UR - http://www.scopus.com/inward/record.url?scp=84859964620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859964620&partnerID=8YFLogxK

U2 - 10.1038/clpt.2012.39

DO - 10.1038/clpt.2012.39

M3 - Article

C2 - 22513312

AN - SCOPUS:84859964620

VL - 91

SP - 771

EP - 773

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 5

ER -